Caldera Health is a biotechnology company with a vision to develop highly accurate prostate cancer diagnostic and prognostic tests. Their technology analyses gene expression levels of selected RNA biomarkers to diagnose prostate cancer and provide a prognosis of disease progression.
Caldera Health's founders were both diagnosed with metastatic prostate cancer, both due to the flaws of the PSA (prostate specific antigen) test and are in a unique position to answer the unmet clinical needs in prostate cancer diagnosis.
Students with an interest in medicine and biomedical technology will have the chance to work with a team that is using new technology to disrupt old diagnostic tests and provide solutions to their limitations.
For more information visit the official website at
Crimson helps shape, manage and motivate students with personalised education packages that dramatically improve admission chances for top-tier universities.
Tap into our network of 2,300+ tutors, mentors and consultants - students or alumni from the best US and UK universities - that live and breathe the success you aspire to achieve.
Contact us here:
j.wright@crimsoneducation.org